Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01161446 · ClinicalTrials.gov registry record · NA

Home Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study)

A NA study of HIV, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
230
Enrollment target
1
Study location

NCT01161446: Completed NA study of HIV, sponsored by University of Washington.

NCT01161446 is a NA study of HIV that has completed, run by University of Washington. The registered enrollment target is 230 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01161446, a NA study of HIV, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
230 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether the availability of home self-testing for HIV will increase HIV testing frequency among men who have sex with men without negatively impacting their risk for HIV acquisition.

Primary Outcome

Number of HIV tests during follow-up reported by participants at end-of-study visit

Conditions Studied

Interventions

  • BEHAVIORAL Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test
  • DEVICE Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test

Study Locations (1)

Washington

  • Public Health - Seattle & King County STD Clinic, located at Harborview Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 230 participants
Start Date 2010-07
Est. Completion 2014-12
Phase NA
University of Washington

1,048 total trials

What the finished NCT01161446 record still lists

NCT01161446 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (48% lower).

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test is the first listed.

NCT01161446 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT01161446 about?

NCT01161446 is a clinical study titled "Home Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study)". The purpose of this study is to determine whether the availability of home self-testing for HIV will increase HIV testing frequency among men who have sex with men without negatively impacting their risk for HIV acquisition.

What is the current status of trial NCT01161446?

This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2010-07. Estimated completion is 2014-12.

What conditions does trial NCT01161446 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT01161446?

The interventions under investigation include: Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test (BEHAVIORAL), Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test (DEVICE).

Who is sponsoring clinical trial NCT01161446?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01161446 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01161446's enrollment target sits among peer trials

230 93rd of 303 higher than 211 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02710253 · 230 participants · Phase 2

    Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

  • NCT02777879 · 230 participants

    Lung Microbiome and Inflammation in Early COPD

  • NCT03824483 · 230 participants · Phase 2

    Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

  • NCT03833622 · 230 participants · NA

    Shared Decision Making to Improve Goals of Care in the ED

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01161446, the US trial registry maintained by the National Library of Medicine. NCT01161446 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.